Clinical evaluation of new vaccines - Scientific guideline
Clinical evaluation of new vaccines - Scientific guideline
Clinical evaluation of new vaccines - Scientific guideline
Human medicines European public assessment report (EPAR): Giotrif, afatinib, Date of authorisation: 25/09/2013, Revision: 16, Status: Authorised
Addendum to the Guideline on clinical development of vaccines to address clinical trials in immunocompromised individuals
Herbal medicinal product: Pilosellae herba cum radice, Hieracium pilosella L., F: Assessment finalised
Agenda - PDCO agenda of the 25-28 February 2025 meeting
EMEA-003063-PIP02-22
EMEA-000786-PIP01-09-M02
Medicinal products for human use: monthly figures - January 2025
CTIS newsflash - 25 February 2025
ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 February 2025, 09:30 (CET) to 20 February 2025, 14:00 (CET)